Skip to main content

Advertisement

SpringerLink
Log in

Striking complete remission after interferon-α for secondary recurrent non-Hodgkin’s lymphoma but rare interferon-induced side effects

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Interferon (IFN) treatment is a therapeutic option in the treatment of non-Hodgkin’s lymphoma (NHL). Although randomized trials have failed to show significant differences in progression-free and overall survival (OS) with IFN compared to placebo after peripheral blood stem cell transplantation (PBSCT) as well as standard therapy for NHL, anecdotal case reports have documented impressive results in selected patients. With this case report, we demonstrate an astounding success of IFN therapy given in the treatment of a young man with second relapse after two consecutive autologous PBSCTs and abdominal irradiation. With occurrence of multiple lymph node enlargements despite this intensive treatment, he received IFN and obtained a well-documented complete remission (CR). Yet, treatment with IFN always has to be considered in the context of its significant side effect profile, which can have considerable impact on the patient’s quality of life as illustrated in this case report.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2A–C

Similar content being viewed by others

References

  1. Antin JH (2002) Long-term care after hematopoietic cell transplantation in adults. N Engl J Med 347:36–42

    Article  PubMed  Google Scholar 

  2. Jonasch E, Haluska FG (2001) Interferon in oncological practice: a review of Interferon biology, clinical applications and toxicities. Oncologist 6:34–55

    CAS  Google Scholar 

  3. Marcellin P, Pouteau M, Renard P, et al. (1992) Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut 33:855–856

    CAS  PubMed  Google Scholar 

  4. Manzano Alonso ML, Munoz Gomez R, Castellano Tortajada G, Solis Herruzo A (2001) IFN-induced anosmia y ageusia in chronic hepatitis C (in Spanish). Gastroenterol Hepatol 24:412

    Google Scholar 

  5. Kraus I, Vitezic D (2000) Anosmia induced with alpha interferon in a patient with chronic hepatitis C. Int J Clin Pharmacol Ther 38:360–361

    CAS  PubMed  Google Scholar 

  6. Cocquyt VF, Van Belle SJ (1994) Anosmia associated with alpha-interferon treatment. Ann Oncol 5:863

    CAS  Google Scholar 

  7. Maruyama S, Hirayama C, Kadowaki Y, et al. (1998) Interferon-induced anosmia in a patient with chronic hepatitis C. Am J Gastroenterol 93:122–123

    Article  CAS  PubMed  Google Scholar 

  8. Spaepen K, Stroobants S, Dupont P, Vendenberghe P, Maertens J, Bormans G, Thomas J, Balzarini J, De Wolf-Peters C, Mortelmans L, Verhoef G (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood 102:53–59

    Article  PubMed  Google Scholar 

  9. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347:89–94

    Article  CAS  PubMed  Google Scholar 

  10. Allen IE, Ross SD, Borden SP, Monroe MW, Kupelnick B, Connelly JE, Ozer H (2001) Meta-analysis to assess the efficacy of Interferon-α in patients with follicular Non-Hodgkin’s Lymphoma. J Immunother 24:58–65

    Article  CAS  PubMed  Google Scholar 

  11. Hagenbeek A, Carde P, Meerwaldt JH, et al. (1998) Maintenance of remission with human recombinant interferon α-2a in patients with stages III and IV low-grade malignant non-Hodgkin’s lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 16:41–47

    CAS  PubMed  Google Scholar 

  12. Enschede SH, Shahidi H, Venogopal P, Riley MB, Huang R, Jajeh A, Preisler HD, Gregory SA (2001) Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin’s lymphoma. Leuk Lymphoma 40:325–334

    CAS  PubMed  Google Scholar 

  13. Palmieri G, Morabito A, Rea A, Caraglia M, Tagliaferri P, Bianco AR (1994) Cytosine arabinoside (ARA-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin’s lymphoma particularly responsive to first-line doxorubicin-containing regimens. Br J Haematol 88:421–423

    CAS  PubMed  Google Scholar 

  14. Porrata LF, Inwards DJ, Lacy MQ, Markovic SN (2001) Immunomodulation of early engrafted killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation. Bone Marrow Transplant 28:673–680

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We thank Professor Dr. R. Mertelsmann (Freiburg) for his continuous support, him and Professor Dr. J. Finke (Freiburg) for critical reading of the manuscript, and Professor Dr. G. Schellong (Münster) for valuable discussion.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany

    Barbara Deschler & Monika Engelhardt

  2. Department of Endocrinology, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany

    Martin Reincke

  3. Department of Radiology, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany

    Thorsten A. Bley

  4. Department of Nuclear Medicine, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany

    Ingo Brink

Authors
  1. Barbara Deschler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Reincke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thorsten A. Bley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ingo Brink
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monika Engelhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Engelhardt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deschler, B., Reincke, M., Bley, T.A. et al. Striking complete remission after interferon-α for secondary recurrent non-Hodgkin’s lymphoma but rare interferon-induced side effects. Ann Hematol 84, 263–266 (2005). https://doi.org/10.1007/s00277-004-0861-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-004-0861-z

Keywords

Search

Navigation